About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Orchid Gets USFDA Nod for Cephalexin

by Medindia Content Team on July 12, 2006 at 8:36 AM
Font : A-A+

Orchid Gets USFDA Nod for Cephalexin

Orchid Chemicals & Pharmaceuticals Ltd today said it has received approval from the USFDA for its ANDA (Abbreviated New Drug Application) of Cephalexin oral suspension.

Cephalexin, an off-patent molecule, forms part of Orchid Chemicals' distribution alliance with US generic pharma major Par Pharmaceuticals Inc, it informed the Bombay Stock Exchange.

Advertisement

Orchid added that its Cephalexin capsules are already marketed in the US through partnership with Par Pharmaceuticals and following this approval, the number of dosage forms, oral solids and injections distributed by it in the US now stands at 12.

The company's shares were trading at Rs 185.30, up 1.12 per cent at the BSE.

Source:PTI News
Advertisement
Advertisement
Advertisement
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Orchid Gets USFDA Nod for Cephalexin Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests